Fig. 4.
Fig. 4. FACS analysis of rVV-infected mature DCs. (A) The top row shows staining for VV1-6B6 early vaccinia protein in uninfected, PLWUV rVV-TK− and live rVV-TK−-infected DCs at an MOI of 2:1. The lower row shows comparable staining for CD25 and CD83, 2 markers for DC maturation, on uninfected DCs (···), PLWUV rVV-infected DCs (—-), and rVV-infected DCs (—). (B) rVV-infected DCs stimulate T-cell proliferative responses in the MLR. Bulk T cells were used as responders towards graded doses of allogeneic DCs that were uninfected or infected with rVV-TK− and PLWUV rVV-TK−. Cultures were pulsed on day 5 for 8 hours with 4 μCi/mL of 3H-TdR. Results are the means of triplicates (mean cpm).

FACS analysis of rVV-infected mature DCs. (A) The top row shows staining for VV1-6B6 early vaccinia protein in uninfected, PLWUV rVV-TK and live rVV-TK-infected DCs at an MOI of 2:1. The lower row shows comparable staining for CD25 and CD83, 2 markers for DC maturation, on uninfected DCs (···), PLWUV rVV-infected DCs (—-), and rVV-infected DCs (—). (B) rVV-infected DCs stimulate T-cell proliferative responses in the MLR. Bulk T cells were used as responders towards graded doses of allogeneic DCs that were uninfected or infected with rVV-TK and PLWUV rVV-TK. Cultures were pulsed on day 5 for 8 hours with 4 μCi/mL of 3H-TdR. Results are the means of triplicates (mean cpm).

Close Modal

or Create an Account

Close Modal
Close Modal